Guido Dalbagni

Memorial Sloan Kettering Cancer Center
United States

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Medicine D-index 80 Citations 22,418 351 World Ranking 11908 National Ranking 6220

Overview

What are the main themes of his work throughout his whole career to date

In his study, Guido Dalbagni carries out multidisciplinary Gene and Carcinoma research. His Carcinoma study typically links adjacent topics like Genetics. His Genetics study frequently draws connections between related disciplines such as Carcinogenesis. Guido Dalbagni carries out multidisciplinary research, doing studies in Carcinogenesis and Tumor progression. Tumor progression is often connected to Cancer in his work. Cancer connects with themes related to Suppressor in his study. His study connects Internal medicine and Suppressor. His Internal medicine study frequently links to related topics such as Tumor suppressor gene. He merges Tumor suppressor gene with Gene in his study.

Guido Dalbagni most often published in these fields:

Gene (100.00%)
Cancer (100.00%)
Internal medicine (100.00%)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Epidemiology and risk factors of urothelial bladder cancer

Maximilian Burger;James W.F. Catto;Guido Dalbagni;H. Barton Grossman.
European Urology (2013)

1904 Citations

Defining Early Morbidity of Radical Cystectomy for Patients with Bladder Cancer Using a Standardized Reporting Methodology

Ahmad Shabsigh;Ruslan Korets;Kinjal C. Vora;Christine M. Brooks.
European Urology (2009)

1318 Citations

Guideline for the Management of Nonmuscle Invasive Bladder Cancer (Stages Ta, T1, and Tis): 2007 Update

M. Craig Hall;Sam S. Chang;Guido Dalbagni;Raj Som Pruthi.
The Journal of Urology (2007)

927 Citations

Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer.

Harry W. Herr;Bernard H. Bochner;Guido Dalbagni;S. Machele Donat.
The Journal of Urology (2002)

814 Citations

Nuclear Overexpression of p53 Protein in Transitional Cell Bladder Carcinoma: A Marker for Disease Progression

Alvaro S. Sarkis;Guido Dalbagni;Carlos Cordon-Cardo;Zuo-Feng Zhang.
Journal of the National Cancer Institute (1993)

641 Citations

Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer.

Bernard H. Bochner;Guido Dalbagni;Michael W. Kattan;Paul Fearn.
Journal of Clinical Oncology (2006)

564 Citations

CYSTECTOMY FOR BLADDER CANCER: A CONTEMPORARY SERIES

Guido Dalbagni;Elizabeth Genega;Mia Hashibe;Zuo-Feng Zhang.
The Journal of Urology (2001)

556 Citations

Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial

Bernard H. Bochner;Guido Dalbagni;Daniel D. Sjoberg;Jonathan Silberstein;Jonathan Silberstein.
European Urology (2015)

493 Citations

Altered Expression of the Retinoblastoma Gene Product: Prognostic Indicator in Bladder Cancer

Carlos Cordon-Cardo;David Wartinger;Daniel Petrylak;Guido Dalbagni.
Journal of the National Cancer Institute (1992)

463 Citations

Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients with urothelial carcinoma of the bladder.

Atreya Dash;Matthew D. Galsky;Andrew J. Vickers;Angel M. Serio.
Cancer (2006)

354 Citations

If you think any of the details on this page are incorrect, let us know.

Frequent Co-Authors

External Links

Personal Website for Guido Dalbagni